Science203d left

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Confidence50%

1% — Unlikely50% — Coin flip99% — Certain

Resolution

Criteria

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.

Source

Kalshi (kalshi.com)

Closes 203d left

Resolves Jan 1, 2028

Created by @dafutr